+---------+----++++------------+ | | | +---------+----++++------------+ | | | +---------+----++++------------+ | | +---------+----++++------------+ |TR-1: | |NOTIFICATION | |OF MAJOR | |INTEREST IN | |SHARESi | +---------+----++++------------+ | | | +---------+----++++------------+ |1. Identity of |AstraZeneca | |the issuer or |plc | |the underlying | | | issuer | | | of existing | | |shares to | | |which voting | | |rights are | | | attached:ii | | +---------+----++++------------+ |2 Reason for | |the | |notification | |(please tick | |the | |appropriate | |box or boxes): | +---------+----++++------------+ |An | X | |acquisition or | | |disposal of | | |voting rights | | +---------+----++++------------+ |An | | |acquisition or | | |disposal of | | |qualifying | | |financial | | |instruments | | |which may | | |result in | | |the | | |acquisition of | | |shares already | | |issued to | | |which voting | | |rights are | | |attached | | +---------+----++++------------+ |An | | |acquisition or | | |disposal of | | |instruments | | |with similar | | |economic | | |effect to | | |qualifying | | |financial | | |instruments | | +---------+----++++------------+ |An event | | |changing the | | |breakdown of | | |voting rights | | +---------+----++++------------+ |Other | | | |(please | | | |specify):| | | +---------+----++++------------+ |3. Full name |The | |of person(s) |Capital | |subject to |Group | |the |Companies, | | notification|Inc. | |obligation: | | |iii | | +---------+----++++------------+ |4. Full name |See | |of |Schedule A | |shareholder(s)| | | (if | | |different from| | |3.):iv | | +---------+----++++------------+ |5. Date of the|1 June | |transaction |2015 | |and date on | | | which the | | |threshold is | | |crossed or | | | reached: v| | +---------+----++++------------+ |6. Date on |2 June | |which issuer |2015 | |notified: | | +---------+----++++------------+ |7. |Below 3% | |Threshold(s) | | |that is/are | | |crossed or | | | reached: vi,| | | vii | | +---------+----++++------------+ | | |||| | +---------+----++++------------+ +---------------+-++-------+--------+-++-----+----+-------++----------++++-----+ ------+ |8. Notified | |details: | +---------------+-++-------+--------+-++-----+----+-------++----------++++-----+ ------+ |A: Voting rights | |attached to shares | |viii, ix | +---------------+-++-------+--------+-++-----+----+-------++----------++++-----+ ------+ |Class/type of |Situation |Resulting | | shares |previous |situation | | if possible| to the |after the | |using |triggering |triggering | | the ISIN CODE| transactio |transaction | | |n | | +---------------+-++-------+--------+-++-----+----+-------++----------++++-----+ ------+ |Number |Number |Number|Number of |% of | | of | of | of |voting |voting | | Shares | Voting |shares| rights |rights x | | | Rights | | | | +---------------+-++-------+--------+-++-----+----+-------++----------++++-----+ ------+ |Direct |Direct |Indirect|Direct |Indirect | | |xi |xii | | | +---------------+-++-------+--------+-++-----+----+-------++----------++++-----+ ------+ |Ordinary |31,704,772|31,704,772 | | | | |2.4088% | |Shares(ISIN: | | | | |30,437,552| | | |GB0009895292) | | | | | | | | +---------------+-++-------+--------+-++-----+----+-------++----------++++-----+ ------+ |ADRs (ISIN: |7,433,161 |7,433,161 | | | | |0.5884% | |US0463531089) | | | | |7,435,104 | | | +---------------+-++-------+--------+-++-----+----+-------++----------++++-----+ ------+ | | +---------------+-++-------+--------+-++-----+----+-------++----------++++-----+ ------+ |B: Qualifying | |Financial | |Instruments | +---------------+-++-------+--------+-++-----+----+-------++----------++++-----+ ------+ |Resulting situation | | after the | |triggering | |transaction | +---------------+-++-------+--------+-++-----+----+-------++----------++++-----+ ------+ |Type of financial |Expiration |Exercise/ |Number of |% of | | instrument | date | Conversio |voting |voting | | |xiii |n Period | rights | right | | | |xiv |that may |s | | | | |be | | | | | | acquired | | | | | |if the | | | | | | instrumen | | | | | |t is | | | | | | exercised | | | | | |/ converted | | | | | |. | | +---------------+-++-------+--------+-++-----+----+-------++----------++++-----+ ------+ | | | | | | +---------------+-++-------+--------+-++-----+----+-------++----------++++-----+ ------+ | | +---------------+-++-------+--------+-++-----+----+-------++----------++++-----+ ------+ |C: Financial | |Instruments with | |similar economic | |effect to | |Qualifying | |Financial | |Instruments xv, xvi | +---------------+-++-------+--------+-++-----+----+-------++----------++++-----+ ------+ |Resulting situation | | after the | |triggering | |transaction | +---------------+-++-------+--------+-++-----+----+-------++----------++++-----+ ------+ |Type of financial|Exercise|Expiration|Exercise/ |Number of |% of | | instrument |price |date xvii | Conversio|voting |voting | | | | |n period |rights |rights | | | | |xviii |instrument |xix, xx | | | | | |refers to | | +---------------+-++-------+--------+-++-----+----+-------++----------++++-----+ ------+ | | | | | |Nominal|Delta | +---------------+-++-------+--------+-++-----+----+-------++----------++++-----+ ------+ | | | +---------------+-++-------+--------+-++-----+----+-------++----------++++-----+ ------+ | | +---------------+-++-------+--------+-++-----+----+-------++----------++++-----+ ------+ |Total (A+B+C) | +---------------+-++-------+--------+-++-----+----+-------++----------++++-----+ ------+ |Number of voting |Percentage | |rights |of | | |voting | | |rights | +---------------+-++-------+--------+-++-----+----+-------++----------++++-----+ ------+ |37,872,656 |2.9972% | +---------------+-++-------+--------+-++-----+----+-------++----------++++-----+ ------+ | | || | | || | | || |||| | | +---------------+-++-------+--------+-++-----+----+-------++----------++++-----+ ------+ +-----------------------------+-----------------------+------------------------- -+ |9. Chain of controlled undertakings through which the voting rights and/or the| | financial instruments are effectively held, if applicable: xxi | +-----------------------------+-----------------------+------------------------- -+ |See Schedule A | +-----------------------------+-----------------------+------------------------- -+ | | +-----------------------------+-----------------------+------------------------- -+ |Proxy Voting: | +-----------------------------+-----------------------+------------------------- -+ |10. Name of the proxy holder: | | +-----------------------------+-----------------------+------------------------- -+ |11. Number of voting rights proxy holder will cease| | | to hold: | | +-----------------------------+-----------------------+------------------------- -+ |12. Date on which proxy holder will cease to hold | | | voting rights: | | +-----------------------------+-----------------------+------------------------- -+ | | +-----------------------------+-----------------------+------------------------- -+ | 13. Additional information:| | | | | +-----------------------------+-----------------------+------------------------- -+ |14. Contact name: | | +-----------------------------+-----------------------+------------------------- -+ |15. Contact telephone number:| | +-----------------------------+-----------------------+------------------------- -+ | | | | +-----------------------------+-----------------------+------------------------- -+ Schedule A As of 1 June 2015 AstraZeneca PLC Number of Shares Percent of Outstanding The Capital Group 37,872,656 2.997% Companies, Inc. (“CG”) holdings Holdings by CG Management Companies and Funds: Capital Guardian Trust 5,512,014 0.436% Company Capital International 165,100 0.013% Limited Capital International 154,992 0.012% Sàrl Capital International, 72,900 0.006% Inc. Capital Research and 31,967,650 2.530% Management Company
Holding(s) in Company
| Source: AstraZeneca PLC